Respiratory samples from cystic fibrosis outpatients were cultured on Sabouraud's dextrose agar (SABD) containing antibiotics, Mycosel, and Scedosporium-selective medium (SceSel؉). Thirty-two (14.7%) of 218 specimens from 11/69 (15.9%) patients yielded a Scedosporium sp., most frequently Scedosporium aurantiacum (17/218). Scedosporium was recovered on SceSel؉, Mycosel, and SABD from 90.6%, 50.0%, and 46.9% of the specimens tested, respectively.
Opportunistic molds are increasingly isolated in respiratory specimens from children and adults with cystic fibrosis (CF) (17) . Scedosporium species are the second most frequently recovered fungi, after Aspergillus fumigatus (4) . Although invasive scedosporiosis is reportedly rare in CF prior to lung transplantation (11) , colonization may be a risk factor for invasive disease posttransplantation, with associated high mortality (14, 19, (21) (22) (23) . The impact of airway colonization by Scedosporium spp. on respiratory function has not been studied; nevertheless, as Scedosporium spp. are resistant to many antifungal agents, colonization may be a relative contraindication to transplantation (18) .
Isolation of multiple fungi from respiratory specimens is frequent (19) . The prevalence of non-Aspergillus molds may be underestimated due to overgrowth of Aspergillus spp. on routine media (4) . A medium (SceSelϩ) containing the selective antifungal agents dichloran and benomyl has been described for the recovery of Scedosporium from environmental samples (16, 20) , but its utility in detecting Scedosporium spp. in clinical specimens has not been determined. No commercial preparation is available. Scedosporium spp. have been identified previously in respiratory specimens from 8.6 to 10% of CF patients (4, 24) . These data were published prior to recent taxonomic reassignments of Scedosporium spp. (9, 10) , and selective media were not used. We therefore compared the performance of two general media and one selective medium for the isolation of Scedosporium spp. from respiratory specimens and prospectively investigated the frequency and species distribution of Scedosporium in CF patients.
Expectorated sputa were collected from consecutive patients at the Westmead Hospital Adult CF Unit (April 2008 to March 2009). Sputa were inoculated onto (i) Sabouraud dextrose agar (SABD; Difco, Becton Dickinson, Franklin Lakes, NJ) containing chloramphenicol (250 mg/liter) and gentamicin (26 mg/ liter), (ii) Mycosel (BBL, Becton Dickinson), and (iii) SceSelϩ medium (20) . Plates were incubated at 30°C in air and examined twice weekly for 28 days. Suspicious colonies were identified to the species level (Aspergillus and Scedosporium spp.) or the genus level (other molds) by standard morphological/ phenotypic methods (7, 9, 10) . Scedosporium strains were identified as Scedosporium prolificans, S. aurantiacum, or S. apiospermum by restriction fragment length analysis of the internal transcribed spacer (ITS) region (8) . ITS sequence analysis was performed on all S. apiospermum isolates and selected S. aurantiacum isolates (8) .
Samples (n ϭ 218) were received from 69 patients. Filamentous fungi were detected in 142 samples (65.1%) from 56 patients (81.2%; Table 1 ). The majority of the fungi (83.9%) were recovered following 6 days of incubation, and 95.1% were recovered following 10 days. Aspergillus spp. were the most frequently recovered, with A. fumigatus isolated in 45.4% of the samples. Scedosporium species were isolated on one or more media from 32 samples (14.7%) from 11 patients (15.9%; Table 1 ). No sample had multiple Scedosporium spp. identified, although 60 (27.5%) sputa contained two or more fungi. Aspergillus spp. were more often present in sputa that contained Scedosporium spp. (25/32; 78.1%) than in sputa that contained Penicillium spp. (6/18; 33.3%), other hyaline hyphomycetes (5/14; 35.7%), or dematiaceous fungi (4/14; 28.6%) (all P values were Ͻ0.01).
Among Scedosporium culture-positive samples, growth was identified on SceSelϩ in 29/32 samples (90.6%), compared with SABD (46.9%) and Mycosel (50.0%) ( Table 2 ). The combination of SABD and Mycosel detected only 19 (59.3%) of the 32 culture-positive sputa. SceSelϩ medium inhibited the growth of Aspergillus spp. in 101 (91.8%) of the 110 samples from which Aspergillus spp. grew on SABD or Mycosel. Growth of Scedosporium was evident at a median of 6 days (range, 3 to 14 days); 96.9% of the isolates were evident after 10 days of incubation.
The Scedosporium species identified by molecular methods are shown in Table 1 . Results obtained by phenotypic and molecular methods were concordant for 24 isolates (75.0%) as follows: S. aurantiacum, 64.7%; S. prolificans, 90.9%; S. apiospermum, 75.0% (9, 10) . Six (35.3%) of 17 S. aurantiacum isolates were misidentified phenotypically as S. apiospermum due to the absence of the characteristic yellow pigment on potato dextrose agar. Four (36.4%) of 11 S. prolificans isolates had nonpigmented hyphae. All failed to grow on Mycosel medium, presumably due to susceptibility to the cycloheximide in the medium. No difference between the rates of recovery of S. aurantiacum and S. apiospermum on Mycosel was observed.
Since respiratory infections are a major cause of morbidity and mortality in CF patients, documentation of colonizing filamentous fungi, including Scedosporium spp., and subsequent study of their role in disease are important. This study is one of the first to evaluate contemporary culture methods for recovery of Scedosporium spp. from respiratory specimens and illustrates the benefits of selective media in detecting occult Scedosporium spp.
The frequency of recovery of Scedosporium spp. in CF respiratory specimens was higher than previously reported (4, 24) . It is unlikely that this finding reflects patient selection bias, given that consecutive patients were enrolled, no patient refused enrolment, and most (95.8%) of the patients produced sputum. Possible explanations include the use of selective media and/or prolonged incubation (4); 6 to 10 days of incubation was required to detect the growth of most of the isolates. Larger-scale studies are required prior to recommending changes in routine laboratory culture practices. Significant geographic differences in the prevalence of clinical isolates have been observed between different regions (1, 5, 15, 25) . Thus, the relatively high proportion of Scedosporium-positive specimens may relate to a higher environmental fungal burden than in other regions (12) ; this hypothesis warrants further study.
The results reported here extend the observations that the recently described species S. aurantiacum is a significant pathogen (8, 13) . The prevalence of S. aurantiacum approximates 20% of the clinical Scedosporium isolates recovered, and chronic lung disease has been identified as a risk factor (8, 13 ). We now demonstrate that S. aurantiacum frequently colonizes the respiratory tracts of Australian CF patients. This is of particular interest since few clinical isolates have been reported to date (9) .
Key findings from this study include the observations that a substantial proportion of Scedosporium species were recovered only on selective media ( Table 2 ). The likely underestimation of Scedosporium colonization in patients with CF highlights the unanswered role of Scedosporium spp. in progressive lung disease and the validity of using Scedosporium colonization as a criterion to argue against lung transplantation (18) . Longitudinal studies using sensitive, culture-based methods and enrolling pre-and posttransplantation patients are required to establish temporal trends and clinical associations and to assess the impact of colonization with these important pathogens. Phenotypic methods for the identification of isolates from clinical specimens may be inaccurate even in laboratories with expertise. Given the differences in antifungal susceptibility between Scedosporium species (6, 10), species identification by reliable methods is recommended, particularly for patients with invasive scedosporiosis. Species-specific risk factors and clinical associations have not been fully elucidated, and thus, genetic characterization for this purpose is also required.
The limitations of the present study are recognized. The briefness of the study period limited the sample size and the number of isolates identified. Rapid molecular-analysis-based tests to detect Scedosporium DNA in respiratory specimens offer improved turnaround times (24) but may yield falsenegative results due to inhibitors present in the PCR. Further, DNA-based methods may be insufficiently sensitive to identify all of the Scedosporium spp. in respiratory secretions (2, 3) . Studies examining the combined use of culture and PCR-based methods to detect Scedosporium colonization are warranted.
In conclusion, we propose that a Scedosporium-selective medium such as SceSelϩ (20) be used in combination with routine media when examining patients with chronic lung diseases, including CF, for filamentous fungi. Sensitive, culture-based methods should be used before lung transplantation to identify all potential pathogens, and species identity should be confirmed by molecular methods.
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